OUSHK PHARMACY LTD

Company number SC740251 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

OUSHK PHARMACY LTD - Analysis Report

Company Number: SC740251

Analysis Date: 2025-07-29 17:15 UTC

Financial Health Assessment Report for Oushk Pharmacy Ltd


1. Financial Health Score: B+

Explanation:
Oushk Pharmacy Ltd exhibits strong liquidity and solid net asset growth within a short operational period since incorporation in 2022. The company has a healthy working capital position and increasing shareholder funds, indicating good financial stability. However, the reliance on related-party royalty payments and concentration of control suggests caution in governance and operational independence. Overall, the company shows promising vitality with manageable risks.


2. Key Vital Signs

Metric 31-Mar-2025 31-Aug-2024 Interpretation
Current Assets £1,759,737 £246,069 Significant growth, indicating improved liquidity position.
Cash at Bank £415,459 £17,831 Healthy cash reserves, a sign of strong cash flow management.
Debtors £1,244,278 £228,238 Large increase; potential risk if receivables are slow to collect.
Current Liabilities £915,529 £125,662 Increased liabilities, but still covered by current assets.
Net Current Assets (Working Capital) £844,208 £120,407 Positive and growing, indicating operational liquidity.
Net Assets (Equity) £850,386 £124,925 Strong growth in equity, reflecting retained earnings and capital injection.
Inventories £100,000 £0 Introduction of stock, appropriate for a pharmacy business.
Shareholders' Funds £850,386 £124,925 Consistent with net assets, showing financial solidity.
Average Number of Employees 3 1 Business scaling up, which may increase operating costs.

Additional Notes:

  • The company benefits from a positive net working capital, which means it has more short-term assets than short-term liabilities—indicating "healthy cash flow" capacity in the short term.
  • Tangible fixed assets increased slightly but remain a small proportion of total assets, which is typical in a service/dispensing business.
  • The large increase in debtors suggests either rapid sales growth or extended credit terms, which could be a "symptom of cash flow stress" if not managed carefully.
  • The company pays significant royalty fees to its parent company, Oushk Ltd (£423,022 in the latest year), which impacts profitability and cash reserves.

3. Diagnosis

Financial Condition:
Oushk Pharmacy Ltd is in a financially sound condition with robust asset growth and strong equity base for a relatively young company. The working capital is comfortably positive, indicating the business can meet its short-term obligations without distress. The sizeable increase in debtors and current liabilities is a symptom of rapid business scaling, possibly reflecting increased sales and operational activity.

Risk Factors:

  • The large debtors balance signals a need for effective credit control to avoid liquidity crunches.
  • Royalty payments to the parent company, which constitute a material cost, could impact profitability and cash flow if sales do not continue to grow.
  • The company is heavily controlled by Oushk Ltd and a key individual, which concentrates decision-making risk.

Operational Outlook:
The increase in employees and inventory suggests the company is expanding its capacity to serve customers, which is positive for future revenues but requires careful management to avoid overextension.


4. Recommendations

  1. Improve Debtors Management:
    Implement stricter credit control policies and regular monitoring to ensure timely collection of receivables, minimizing the risk of cash flow interruption.

  2. Review Related-Party Transactions:
    Assess the commercial terms of royalty payments to Oushk Ltd to ensure they are sustainable and do not excessively drain profitability.

  3. Strengthen Governance:
    Consider broadening the board or introducing independent oversight to mitigate risks from concentrated control and improve strategic decisions.

  4. Monitor Liquidity Metrics Regularly:
    Keep a close watch on cash flow forecasts and working capital ratios, especially as the business scales, to avoid symptoms of financial distress.

  5. Inventory Management:
    Optimize inventory levels to balance meeting customer demand without tying up excessive capital in stock.

  6. Plan for Profitability:
    While current assets and equity are strong, focus on converting sales growth into sustainable operating profits.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.